Literature DB >> 21631627

Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas chromatography/mass spectrometry.

Felix Sahm1, David Capper, Stefan Pusch, Jörg Balss, Arend Koch, Claus-Dieter Langhans, Jürgen G Okun, Andreas von Deimling.   

Abstract

Mutations in the isocitrate dehydrogenase (IDH) 1 and 2 genes occur frequently in diffuse astrocytoma and oligodendroglioma. The consecutive amino acid substitutions in the mutant proteins result in a gain of the function to catalyze the reduction of alpha-ketoglutarate to 2-hydroxyglutarate (2HG). So far, all investigated IDH mutations share this gain of function. We here describe a method to detect 2HG levels in archival formalin-fixed paraffin-embedded tumor specimens by stable isotope dilution using gas chromatography followed by mass spectrometry (GC/MS). While 2HG levels are notably decreased during the routine embedding process, preserved amounts are still sufficient to indicate a mutation. Detection of 2HG in archival specimens could make routinely processed tissue accessible for research on 2HG accumulation and may allow studies on correlation with clinical data.
© 2011 The Authors; Brain Pathology © 2011 International Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631627     DOI: 10.1111/j.1750-3639.2011.00506.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  26 in total

Review 1.  Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target.

Authors:  Changcun Guo; Christopher J Pirozzi; Giselle Y Lopez; Hai Yan
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

2.  Mutant IDH Sensitizes Gliomas to Endoplasmic Reticulum Stress and Triggers Apoptosis via miR-183-Mediated Inhibition of Semaphorin 3E.

Authors:  Ying Zhang; Stefan Pusch; James Innes; Kastytis Sidlauskas; Matthew Ellis; Joanne Lau; Tedani El-Hassan; Natasha Aley; Francesca Launchbury; Angela Richard-Loendt; Jasper deBoer; Sheng Chen; Lei Wang; Andreas von Deimling; Ningning Li; Sebastian Brandner
Journal:  Cancer Res       Date:  2019-08-07       Impact factor: 12.701

3.  High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue.

Authors:  Alice Ly; Achim Buck; Benjamin Balluff; Na Sun; Karin Gorzolka; Annette Feuchtinger; Klaus-Peter Janssen; Peter J K Kuppen; Cornelis J H van de Velde; Gregor Weirich; Franziska Erlmeier; Rupert Langer; Michaela Aubele; Horst Zitzelsberger; Liam McDonnell; Michaela Aichler; Axel Walch
Journal:  Nat Protoc       Date:  2016-07-14       Impact factor: 13.491

4.  High incidence of maternal vitamin B12 deficiency detected by newborn screening: first results from a study for the evaluation of 26 additional target disorders for the German newborn screening panel.

Authors:  Gwendolyn Gramer; Junmin Fang-Hoffmann; Patrik Feyh; Glynis Klinke; Peter Monostori; Jürgen G Okun; Georg F Hoffmann
Journal:  World J Pediatr       Date:  2018-06-15       Impact factor: 2.764

5.  DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria.

Authors:  Katharina Danhauser; Sven W Sauer; Tobias B Haack; Thomas Wieland; Christian Staufner; Elisabeth Graf; Johannes Zschocke; Tim M Strom; Thorsten Traub; Jürgen G Okun; Thomas Meitinger; Georg F Hoffmann; Holger Prokisch; Stefan Kölker
Journal:  Am J Hum Genet       Date:  2012-11-08       Impact factor: 11.025

Review 6.  Emerging insights into the molecular and cellular basis of glioblastoma.

Authors:  Gavin P Dunn; Mikael L Rinne; Jill Wykosky; Giannicola Genovese; Steven N Quayle; Ian F Dunn; Pankaj K Agarwalla; Milan G Chheda; Benito Campos; Alan Wang; Cameron Brennan; Keith L Ligon; Frank Furnari; Webster K Cavenee; Ronald A Depinho; Lynda Chin; William C Hahn
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

7.  Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate.

Authors:  Bi-Feng Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.

Authors:  Shipra Agarwal; Mehar Chand Sharma; Prerana Jha; Pankaj Pathak; Vaishali Suri; Chitra Sarkar; Kunzang Chosdol; Ashish Suri; Shashank Sharad Kale; Ashok Kumar Mahapatra; Pankaj Jha
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

9.  Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemia.

Authors:  J Balss; C Thiede; T Bochtler; J G Okun; M Saadati; A Benner; S Pusch; G Ehninger; M Schaich; A D Ho; A von Deimling; A Krämer; C E Heilig
Journal:  Leukemia       Date:  2015-11-19       Impact factor: 11.528

10.  GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.

Authors:  Satoshi Nakamizo; Takashi Sasayama; Masakazu Shinohara; Yasuhiro Irino; Shin Nishiumi; Masamitsu Nishihara; Hirotomo Tanaka; Kazuhiro Tanaka; Katsu Mizukawa; Tomoo Itoh; Masaaki Taniguchi; Kohkichi Hosoda; Masaru Yoshida; Eiji Kohmura
Journal:  J Neurooncol       Date:  2013-03-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.